Bot, AdrianBrewer, Joanna EEshhar, ZeligFrankel, Stanley RHickman, EmmaJungbluth, Achim AMorgan, RichardPeretz, YoavRadvanyi, LaszloRamos, Carlos ARobbins, Paul FWucherpfennig, Kai2015-08-032015Bot, A., J. E. Brewer, Z. Eshhar, S. R. Frankel, E. Hickman, A. A. Jungbluth, R. Morgan, et al. 2015. “Target discovery for T cell therapy: next steps to advance Immunotherapies.” Journal for Immunotherapy of Cancer 3 (1): 31. doi:10.1186/s40425-015-0061-5. http://dx.doi.org/10.1186/s40425-015-0061-5.2051-1426http://nrs.harvard.edu/urn-3:HUL.InstRepos:17820802Investigators from academia and industry gathered on August 14, 2014, in Boston at the Inaugural ImVacS conference entitled “Target Discovery for T Cell Therapy: Next Step to Advance Immunotherapies”. Novel targets, discovery strategies and enabling technologies were presented and discussed.en-USImmunotherapyAdoptive T cell therapyChimeric antigen receptorsT cell receptorsTumor infiltrating lymphocytesTargetsAntibodiesVaccinesJournal Article2015-08-0310.1186/s40425-015-0061-5